Performance of HPV E4 and p16 INK4a biomarkers in predicting regression of cervical intraepithelial neoplasia grade 2 (CIN2): protocol for a historical cohort study.

MLA

Damgaard, Rikke Kamp, et al. “Performance of HPV E4 and P16 INK4a Biomarkers in Predicting Regression of Cervical Intraepithelial Neoplasia Grade 2 (CIN2): Protocol for a Historical Cohort Study.” BMJ Open, vol. 12, no. 7, July 2022, p. e059593. EBSCOhost, https://doi.org/10.1136/bmjopen-2021-059593.

APA

Damgaard, R. K., Jenkins, D., de Koning, M. N., Quint, W. G., Stoler, M. H., Doorbar, J., Kahlert, J., Gravitt, P. E., Steiniche, T., Petersen, L. K., & Hammer, A. (2022). Performance of HPV E4 and p16 INK4a biomarkers in predicting regression of cervical intraepithelial neoplasia grade 2 (CIN2): protocol for a historical cohort study. BMJ Open, 12(7), e059593. https://doi.org/10.1136/bmjopen-2021-059593

Chicago

Damgaard, Rikke Kamp, David Jenkins, Maurits Nc de Koning, Wim Gv Quint, Mark H Stoler, John Doorbar, Johnny Kahlert, et al. 2022. “Performance of HPV E4 and P16 INK4a Biomarkers in Predicting Regression of Cervical Intraepithelial Neoplasia Grade 2 (CIN2): Protocol for a Historical Cohort Study.” BMJ Open 12 (7): e059593. doi:10.1136/bmjopen-2021-059593.